baylor-logo-wire-500x500.jpg
Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024
January 23, 2024 09:00 ET | Baylor Genetics
Showcase Presentation to Include Case Examples from NIH’s Undiagnosed Diseases Network (UDN)
TelesisBio_Logo_RGB.png
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
September 28, 2023 15:48 ET | Telesis Bio
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp®...
Mark Morgan
Dante Labs Announces Appointment of Healthcare Veteran and GRAIL SVP Mark Morgan to Board Of Directors to Support Genomic and Precision Medicine Scaling in the United States
August 09, 2021 07:39 ET | Dante Labs
CAMBRIDGE, United Kingdom, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announced today the appointment of Mark Morgan as a board member. Mark is...
dantelabs_marchio_positivo.png
Dante Labs appoints Illumina acclaimed COO Bob Ragusa as Board Member to support the execution of its global integrated precision medicine strategy
July 19, 2021 07:07 ET | Dante Labs
Bob Ragusa leads Illumina global operations and is a key contributor to Illumina's growth and global scaling.Dante Labs integrated precision medicine offering leverages the intersection of local lab...
Dante Labs Clinical Laboratory
Dante Labs commits to ending Rare Disease Odysseys globally through Stripe2be: a patient-centric whole genome based solution tailored for rare disease patients
July 08, 2021 04:00 ET | Dante Labs
Stripe2be uses an unbiased approach to Whole Genome Sequencing (WGS) for rare diseases: combining the information submitted from both personal patient records and statements, and using the Dante Labs...
Logo.jpg
ProPhase Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries
June 10, 2021 08:30 ET | ProPhase Labs, Inc.
ProPhase Precision Medicine, Inc. and ProPhase Global Healthcare, Inc. to Expand Opportunities in Genomics and International Testing Services ProPhase Diagnostics, Inc. Developing New Testing...